Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, April 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy: 1 policy source

patent: 2 patents

Citations

dimensions_citation: 93 Dimensions

Readers on

mendeley: 97 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

BIOLOGICAL MARKERS AND METHODS FOR PREDICTING RESPONSE TO B-CELL ANTAGONISTS

Application WO-2012118750-A2

World Intellectual Property Organisation (WIPO)

METHOD FOR EVALUATING THE RESPONSE OF RHEUMATOID ARTHRITIS PATIENTS TO THERAPY AND FOR…

Application WO-2011085811-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.